Skip to content

Circulating microparticles in obesity

MIcroparticles in PAThophysiology of OBesity

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN22061598
Enrollment
410
Registered
2015-04-26
Start date
2011-12-01
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Domain of adult obesity Nutritional, Metabolic, Endocrine

Interventions

1. Anthropometrics (body measurements) 2. Biological parameters and microvascular function (e.g. blood pressure, pulse rate)

Sponsors

Sousse University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adults with BMI = 30kg/m²

Exclusion criteria

Exclusion criteria: 1. History of hypertension, antihypertensive medication or elevated sitting blood pressure (systolic blood pressure (SBP) = 140 mmHg and/or diastolic blood pressure (DBP) = 90 mmHg) 2. History of diabetes mellitus or fasting glucose > 7mmol/L 3. Any history or finding of cardiovascular disease, and/or undergone any cardiovascular procedures 4. Hyperlipidemia (total cholesterol > 6,7 mmol/L and/or triglycerides levels > 4,5 mmol/L) 5. Smoking 6. Consumption of any vasoactive medications or antioxidant supplements within the past 6 months

Design outcomes

Primary

MeasureTime frame
1. Microvascular assessment of cutaneous blood flow performed by the laser Doppler flowmetry technique at diagnosis and after exercise training 2. Plasma microparticules quantification and characterization by Flow cytometry at diagnosis and after exercise training

Secondary

MeasureTime frame
1. Circulating microparticles level 2. Informed written consent before inclusion

Countries

Tunisia

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026